Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 8
1966 9
1967 8
1968 10
1969 5
1970 5
1971 13
1972 7
1973 9
1974 6
1975 7
1976 6
1977 9
1978 11
1979 17
1980 13
1981 12
1982 12
1983 9
1984 23
1985 31
1986 24
1987 65
1988 34
1989 26
1990 23
1991 15
1992 15
1993 15
1994 11
1995 13
1996 15
1997 15
1998 21
1999 36
2000 39
2001 34
2002 38
2003 43
2004 38
2005 37
2006 34
2007 33
2008 40
2009 38
2010 47
2011 50
2012 51
2013 69
2014 64
2015 84
2016 79
2017 109
2018 142
2019 137
2020 177
2021 169
2022 185
2023 196
2024 128

Search Results

2,299 results

Results by year

Filters applied: . Clear all
Page 1
Androgenetic Alopecia: Therapy Update.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Devjani S, et al. Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11. Drugs. 2023. PMID: 37166619 Free PMC article. Review.
Drug-induced alopecia areata: A systematic review.
Ezemma O, Devjani S, Jothishankar B, Kelley KJ, Senna M. Ezemma O, et al. J Am Acad Dermatol. 2024 Jan;90(1):133-134. doi: 10.1016/j.jaad.2023.05.022. Epub 2023 May 18. J Am Acad Dermatol. 2024. PMID: 37207950 No abstract available.
Alopecia areata: current therapy.
Fiedler VC. Fiedler VC. Cleve Clin J Med. 1989 Mar-Apr;56(2):122-3. doi: 10.3949/ccjm.56.2.122. Cleve Clin J Med. 1989. PMID: 2731333 Free article. No abstract available.
Janus kinase inhibitors for alopecia areata.
King BA, Craiglow BG. King BA, et al. J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049. J Am Acad Dermatol. 2023. PMID: 37591562 Review.
European expert consensus statement on the systemic treatment of alopecia areata.
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, Olszewska M, Ovcharenko YS, Piraccini BM, Prohic A, Rakowska A, Reygagne P, Richard MA, Soares RO, Starace M, Vañó-Galvan S, Waskiel-Burnat A. Rudnicka L, et al. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2. J Eur Acad Dermatol Venereol. 2024. PMID: 38169088 Review.
Baricitinib in Alopecia Areata.
Messenger A, Harries M. Messenger A, et al. N Engl J Med. 2022 May 5;386(18):1751-1752. doi: 10.1056/NEJMe2203440. N Engl J Med. 2022. PMID: 35507486 No abstract available.
Microneedling for Hair Loss.
Gupta AK, Quinlan EM, Venkataraman M, Bamimore MA. Gupta AK, et al. J Cosmet Dermatol. 2022 Jan;21(1):108-117. doi: 10.1111/jocd.14525. Epub 2021 Oct 29. J Cosmet Dermatol. 2022. PMID: 34714971 Review.
Ritlecitinib: First Approval.
Blair HA. Blair HA. Drugs. 2023 Sep;83(14):1315-1321. doi: 10.1007/s40265-023-01928-y. Drugs. 2023. PMID: 37556041 Free PMC article. Review.
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
King B, Zhang X, Harcha WG, Szepietowski JC, Shapiro J, Lynde C, Mesinkovska NA, Zwillich SH, Napatalung L, Wajsbrot D, Fayyad R, Freyman A, Mitra D, Purohit V, Sinclair R, Wolk R. King B, et al. Lancet. 2023 May 6;401(10387):1518-1529. doi: 10.1016/S0140-6736(23)00222-2. Epub 2023 Apr 14. Lancet. 2023. PMID: 37062298 Clinical Trial.
2,299 results